ArticleOncogene2022

Genome engineering for estrogen receptor mutations reveals differential responses to anti-estrogens and new prognostic gene signatures for breast cancer.

Alison Harrod et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.